Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report

Fig. 1

HCMV DNAemia levels in IU/mL detected in whole blood (red line) are shown. Moreover, timeline of medication, including immunosuppressive regimens (tacrolimus and steroid) as well as antiviral therapies (vGCV, GCV, FOS, CDV, LMV and anti-HCMV IgG) is given in the graph. Occurrence of drug resistance (GCV and LMV) are also shown

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us